Abstract:Deregulated and aberrant expression of microRNAs (miRNAs) have been linked to a variety of disorders such as cancers, autoimmune diseases, and chronic inflammation. Many miRNAs are important regulators of cellular processes involving development, differentiation, and signaling. We investigated whether miR155, a multifunctional miRNA induced by inflammatory cytokines and involved in hematopoiesis, inflammatory disorders, and macrophage activation, has any promise in reducing tumor burden in a transgenic breast cancer model. To study the effects of miR155 in breast cancer, our lab developed the first MMTV‐PyMT mice deficient for miR155 on a C57BL/6 background. Four‐week‐old female PyMT (n=12) and PyMT/miR155‐/‐ (n=11) mice were euthanized at 19 weeks of age. miR155 deficient mice exhibited reduced tumor number and volume palpations (p<0.05) at approximately 16 weeks of age. Reduced tumor burden displayed in miR155 deficient mice was also confirmed by histopathological analysis. The majority (60%) of miR155 deficient mice exhibited a lower degree of dysplasia characterized as adenoma/mammary intraepithelial neoplasia (MIN), whereas all PyMT mice progressed into the early and late invasive carcinoma grade. Upon euthanizing, mammary glands were excised from tumors for RT‐PCR, and tumors were counted, measured, and weighed. PyMT mice deficient in miR155 exhibited reduced tumor volume (p<0.05), number (p<0.05), and weight (p<0.05). To investigate the anti‐tumoral effects associated with miR155 deficiency, mammary glands excised from tumors were analyzed to examine inflammatory mediators and macrophage markers within the mammary tumor environment. We demonstrate that miR155 deficiency upregulates suppressor of cytokine signaling 1 (SOCS1) resulting in reduced overall cytokines, and reduced macrophages as indicated by CD68 and Integrin Subunit Alpha X (IGTAX). Mammary glands of miR155‐/‐ mice had reduced pro‐inflammatory M1 macrophage cytokines as indicated by reduced interleukin‐1‐beta (IL‐1b), IL‐6, and tumor necrosis factor‐alpha (TNF‐a). Mammary glands excised from tumors of mice deficient in miR155 exhibited even greater inhibition of M2 macrophages, important in reducing inflammation and contributing to tumor growth and immunosuppressive function, as indicated by reduced IL‐4, IL‐10, IL‐13, mannose receptor 1 (Mrc1), and TNF‐beta. Given that macrophages are known to promote tumorigenesis, we suggest that the anti‐tumor effects of miR155 inhibition are due to its upregulation of SOCS1 and resulting decrease in pro‐tumor M2 macrophages.

Nur77 Deficiency in Mice Accelerates Tumor Invasion and Metastasis by Facilitating TNFα Secretion and Lowering CSF-1R Expression

Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2.

A Role for the Orphan Steroid Receptor Nur77 in Apoptosis Accompanying Antigen-Induced Negative Selection.

Neuromedin U Receptor 1 Deletion Leads to Impaired Immunotherapy Response and High Malignancy in Colorectal Cancer

Nuclear receptor Nur77 regulates immunomechanics of macrophages

Tumor necrosis factor receptor signaling modulates carcinogenesis in a mouse model of breast cancer

The Orphan Nuclear Receptor Nur77 Suppresses Endothelial Cell Activation Through Induction of IκBα Expression

Blocking Ppar Gamma Interaction Facilitates Nur77 Interdiction Of Fatty Acid Uptake And Suppresses Breast Cancer Progression

Top issues in providing successful undergraduate research experiences

Nur77 knock-down suppresses glioma by regulating CXCR4

Hypoxia-induced Nur77 activates PI3K/Akt signaling via suppression of Dicer/let-7i-5p to induce epithelial-to-mesenchymal transition

Myeloid NEMO deficiency promotes tumor immunosuppression partly via MCP1-CCR2 axis

Nur77-IRF1 axis inhibits esophageal squamous cell carcinoma growth and improves anti-PD-1 treatment efficacy

Aneurysm contents as a source of graft infection.

Expression of mouse CD47 on human cancer cells profoundly increases tumor metastasis in murine models

Nur77 Mediates Anaphylaxis by Regulating miR-21a

Abstract 157: Nur77 Ameliorate Brain Ischemic Injury Through Polarize Microglia from M1 to M2 Phenotype

Nur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome-Mediated Inflammation and Accelerates Atherosclerosis

Proteomic Analysis of the Effects of Nur77 on Lipopolysaccharide-Induced Microglial Activation.

Role of miRNA‐155 on tumorigenesis in a transgenic mouse model of breast cancer

Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function